F S&P 500
5,559.00 +13.00 (+0.23%) F Dow Jones
39,536.00 -14.00 (-0.04%) F Nasdaq
20,121.75 +82.25 (+0.41%) E-mini Russell 2000 Index Futur
2,066.30 +6.20 (+0.30%) Petróleo
82.09 +0.35 (+0.43%) Oro
2,331.30 -5.30 (-0.23%)
Micro-X Limited (MCRXF)
Micro-X Limited
A14, 6 MAB Eastern Promenade
1284 South Road
Tonsley, SA 5042
Australia
61 8 7099 3966
https://www.micro-x.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Kingsley Hall BEC | Chief Executive Officer | 257.95k | N/D | N/D |
| Mr. Anthony Skeats MEng (Hons) | Chief Operating Officer | 238.41k | N/D | N/D |
| Dr. Brian Gonzales Ph.D. | CEO of US & Chief Scientific Officer | 197.18k | N/D | N/D |
| Mr. Tom Jobling | Financial Controller | N/D | N/D | N/D |
| Ms. Bree Farrugia | General Counsel | N/D | N/D | N/D |
| Ms. Rebecca Puddy | Head of Corporate Communications | N/D | N/D | N/D |
| Mr. Scott Bryant | Chief Sales Officer | N/D | N/D | N/D |
| Mr. Alexander Blackburn BEng (Hons), M.B.A. | Head of Strategy & Planning and GM of X-Ray Cameras | 155.9k | N/D | N/D |
Descripción
Micro-X Limited designs, develops, manufactures, and commercializes medical and security imaging products using cold cathode X-ray technology for the healthcare and security markets in Australia. The company offers rover veterinary, a mobile X-ray machine to diagnose and treat animals for general veterinarian practices; rover medical; IED X-ray cameras; miniature baggage scanners to detect hidden threats within passenger carry-on luggage; brain CT scanners for use in road and air ambulances; and DRX-Revolution Nano, a mobile X-ray imaging machine used for high intensity workflow diagnostic medical imaging in hospitals. The company was incorporated in 2011 and is based in Tonsley, Australia.
Gestión corporativa
La calificación ISS Governance QuickScore de Micro-X Limited a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
